Oncology News

Young adults with cancer who were eligible for the Affordable Care Act’s dependent care expansion had greatly improved survival times during the first decade of the ACA, an analysis in Cancer showed.

An NCI grant will fund research designed to better coordinate care for cancer survivors with cardiovascular risks.

The FDA approved Exact Sciences’ Cologuard Plus multitarget stool DNA test to screen adults aged 45 years or older at average risk for colorectal cancer, according to a company press release.

In this episode, host Shikha Jain, MD, speaks with Annmarie Ison about developing safe and accurate software, how software can improve health care disparities and more.

Skin cancer is the most prevalent cancer in the United States, with an estimated 97,610 new cases of invasive melanoma, 89,070 cases of in situ melanoma and about 7,990 deaths from the disease in 2023.

In this episode of Meeting Mic, we bring you pearls and perspectives from the 2024 World Conference on Lung Cancer, as well as Healio’s top headlines from the meeting.

Adults diagnosed with endogenous Cushing’s syndrome have a higher risk for developing cancer compared with controls without the condition, according to data published in the European Journal of Endocrinology.

Greater utilization of genetic testing among men could have considerable benefits with regard to detection, risk management and personalized treatment of cancers, according to authors of a review published in JAMA Oncology.

In this episode, host Shikha Jain, MD, speaks with Brian Fiske about bringing biotech business ideas to fruition, antibody drug conjugate developments and more.